The most important division in the pharmaceutical sector is Quality Assurance. All actions carried out in a pharmaceutical firm, including research, raw material storage, quality control, production, and sales, must first receive clearance from the quality assurance (QA) department. The pharmaceutical items are made to a safe and reliable degree of quality thanks to QA. The QA department is in charge of approving a variety of procedures that lead to the production of a high-quality product. Pharmaceutical Firms work to provide high-quality goods in order to uphold their reputation, boost profits, and provide the greatest possible treatments for people. The goal of QA is to develop products that are up to par with all metrics in quality inspections and adhere to all aspects of Pharmacopoeia Requirements. A pharmaceutical manufacturing business's quality assurance department is essential; without it, it is impossible to envision how any Pharmaceutical Manufacturing Company could produce high-quality products. In reality, quality assurance should be established before the firm begins production since QA must create a large number of papers to serve as a guide for the manufacturing process. A manufacturing company's other operations and manufacturing are conducted in a disciplined environment thanks to quality assurance. Every employee in the firm is given duties by QA. Strong quality control may ensure that the manufacturing business produces high-quality products. QA acts as the FDA representative in the production facility, ensuring that the final product conforms with all quality standards.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada